Zobrazeno 1 - 10
of 79
pro vyhledávání: ''
Publikováno v:
Vascular Medicine (London, England)
Abdominal aortic aneurysm (AAA) is an important vascular disease carrying significant mortality implications due to the risk of aneurysm rupture. Current management relies exclusively on surgical repair as there is no effective medical therapy. A key
Autor:
Jeffrey S. Berger, Marc P. Bonaca, Brian G. Katona, Judith Hsia, Kenneth W. Mahaffey, Iris Baumgartner, W. Schuyler Jones, Charles W. Hopley, Sarah Kavanagh, Manesh R. Patel, William R. Hiatt, Juuso I. Blomster, Frank W. Rockhold, Gerry Fowkes, Lars Norgren
Publikováno v:
Vascular Medicine. 26:608-612
Patients with chronic kidney disease may develop new or more severe anemia when treated with antiplatelet agents due to blood loss in conjunction with impaired erythropoiesis. Because anemia independently predicts limb amputation and mortality among
Autor:
Martin Ursli, Thomas Wrba, Clemens Höbaus, Renate Koppensteiner, Sarah Mohammed Yussef, Gerit-Holger Schernthaner
Publikováno v:
Vascular Medicine (London, England)
Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with chronic kidney disease (CKD) severity and peripheral artery disease (PAD). We hypothesize an association of PAD severity and suPAR in patients without advanced CKD and f
Autor:
Ziyun Jiang, Junfang Zuo
Publikováno v:
Vascular Medicine. 25:295-301
Preeclampsia is a life-threatening multiorgan systemic disease with manifestations including gestational hypertension, oxidative stress, and vascular dysfunction. We aimed to evaluate the therapeutic effects of melatonin on an L-NAME (NLG-nitro-l-arg
Autor:
Jeffrey W. Olin, Arman Qamar, David A. Morrow, Marc P. Bonaca, Benjamin M. Scirica, Joshua A. Beckman, Sabina A. Murphy, Mark A. Creager
Publikováno v:
Vascular Medicine. 25:124-132
Intensive antithrombotic therapy reduces major adverse cardiovascular events (MACE) and major adverse limb events (MALE) in patients with peripheral artery disease (PAD). Recent studies have suggested heterogeneity in risk and benefit in those with a
Autor:
Denise Yates, Mustafa M Shennak, Tianke Wang, Elizabeth V Ratchford, Timothy Clough, James Fulmer, William B. Smith, Laurence Colin, Oliver J. Müller, Holger Lawall, Lucy LaPerna, Alpa Patel, Christopher M. Kramer, Kerry S Russell, Ping Mahling, Sigrid Nikol, Craig T. Basson, Andrea Feller
Publikováno v:
Vascular Medicine. 24:414-421
Extensive atherosclerotic plaque burden in the lower extremities often leads to symptomatic peripheral artery disease (PAD) including impaired walking performance and claudication. Interleukin-1β (IL-1β) may play an important pro-inflammatory role
Autor:
Subhash Banerjee, Marwan Saad, Andrew Mekaiel, Mehdi H. Shishehbor, Peter A. Soukas, Bishoy Abraham, Michael Megaly
Publikováno v:
Vascular Medicine. 24:313-323
The role of cilostazol after endovascular therapy (EVT) of peripheral artery disease (PAD) remains unclear. We conducted a meta-analysis for all studies reporting the outcomes of cilostazol after EVT of PAD from January 2000 through November 2018 wit
Autor:
Samy Selim, Jay Giri, Hai Xu, Andrew Galmer, Gaurav Rao, Ido Weinberg, Mitchell D. Weinberg, Jason J Wang, Michael R. Jaff, Raghu Kolluri, Joe F. Lau
Publikováno v:
Vascular Medicine. 24:241-247
Both catheter-directed thrombolysis (CDT) and ultrasound-assisted thrombolysis (USAT) are novel treatment modalities for patients presenting with acute pulmonary embolism (PE). The objective of this study was to compare clinical and quality-of-life (
Publikováno v:
Vascular Medicine. 24:132-140
Patients with peripheral artery disease (PAD) are at high risk for ischemic cardiovascular complications. While single antiplatelet therapy (SAPT), predominantly aspirin, has long been the standard antithrombotic treatment in stable PAD, there have n
Autor:
Ido Weinberg, Mary Deborah Hines, Bruce L. Mintz, Guang-Ming Tan, Ari J. Mintz, Robert M. Schainfeld, Jorge Borges, Michael R. Jaff
Publikováno v:
Vascular Medicine. 24:50-55
Amphetamine and its related derivatives and analogues (ADRA) are highly addictive central nervous system stimulants that are used commonly in the treatment of attention-deficit/hyperactivity disorder and narcolepsy. These medications are associated w